TY - JOUR
AU - Walle, Thomas
AU - Kraske, Joscha
AU - Liao, Boyu
AU - Lenoir, Bénédicte
AU - Timke, Carmen
AU - von Bohlen Und Halbach, Emilia
AU - Tran, Florian
AU - Griebel, Paul
AU - Albrecht, Dorothee
AU - Ahmed, Azaz
AU - Suarez-Carmona, Meggy
AU - Jiménez-Sánchez, Alejandro
AU - Beikert, Tizian
AU - Tietz-Dahlfuß, Alexandra
AU - Menevse, Ayse Nur
AU - Schmidt, Gabriele
AU - Brom, Manuela
AU - Pahl, Jens H W
AU - Antonopoulos, Wiebke
AU - Miller, Matthias
AU - Perez, Ramon Lopez
AU - Bestvater, Felix
AU - Giese, Nathalia A
AU - Beckhove, Philipp
AU - Rosenstiel, Philip
AU - Jäger, Dirk
AU - Strobel, Oliver
AU - Pe'er, Dana
AU - Halama, Niels
AU - Debus, Jürgen
AU - Cerwenka, Adelheid
AU - Huber, Peter
TI - Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8.
JO - Science advances
VL - 8
IS - 12
SN - 2375-2548
CY - Washington, DC [u.a.]
PB - Assoc.
M1 - DKFZ-2022-00529
SP - eabh4050
PY - 2022
N1 - #EA:E055#LA:E055#
AB - Radiotherapy is a mainstay cancer therapy whose antitumor effects partially depend on T cell responses. However, the role of Natural Killer (NK) cells in radiotherapy remains unclear. Here, using a reverse translational approach, we show a central role of NK cells in the radiation-induced immune response involving a CXCL8/IL-8-dependent mechanism. In a randomized controlled pancreatic cancer trial, CXCL8 increased under radiotherapy, and NK cell positively correlated with prolonged overall survival. Accordingly, NK cells preferentially infiltrated irradiated pancreatic tumors and exhibited CD56dim-like cytotoxic transcriptomic states. In experimental models, NF-κB and mTOR orchestrated radiation-induced CXCL8 secretion from tumor cells with senescence features causing directional migration of CD56dim NK cells, thus linking senescence-associated CXCL8 release to innate immune surveillance of human tumors. Moreover, combined high-dose radiotherapy and adoptive NK cell transfer improved tumor control over monotherapies in xenografted mice, suggesting NK cells combined with radiotherapy as a rational cancer treatment strategy.
LB - PUB:(DE-HGF)16
C6 - pmid:35319989
DO - DOI:10.1126/sciadv.abh4050
UR - https://inrepo02.dkfz.de/record/179247
ER -